Home NDC 0456-4020-63 Celexa
Product NDC 0456-4020
Requested package NDC 0456-4020-63
11-digit product format 004564020
Labeler code 0456
Product ID 0456-4020_0eee9751-8886-474c-a806-8003e90cb151
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name citalopram
Dosage form TABLET, FILM COATED
Route ORAL
Labeler Allergan, Inc.
Application NDA020822
Marketing category NDA
Marketing start 1998-07-17
Substance CITALOPRAM HYDROBROMIDE
Active strength 20 mg/1
Pharmacologic classes Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 12 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Snapshot, Source SHA-256 table Captured / source date Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 557ba5c1ecfa…9c80585c8c6e…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 4 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N020822-001 CELEXA CITALOPRAM HYDROBROMIDE EQ 10MG BASE TABLET / ORAL AB RLD 2000-04-27 N020822-002 CELEXA CITALOPRAM HYDROBROMIDE EQ 20MG BASE TABLET / ORAL AB RLD 1998-07-17 N020822-003 CELEXA CITALOPRAM HYDROBROMIDE EQ 40MG BASE TABLET / ORAL AB RLD, RS 1998-07-17 N020822-004 CELEXA CITALOPRAM HYDROBROMIDE EQ 60MG BASE TABLET / ORAL 1998-07-17
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 3 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 5 · 164 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N020822-001 CELEXA EQ 10MG BASE TABLET / ORAL AB RLD 2000-04-27 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N020822-002 CELEXA EQ 20MG BASE TABLET / ORAL AB RLD 1998-07-17 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N020822-003 CELEXA EQ 40MG BASE TABLET / ORAL AB RLD, RS 1998-07-17 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N020822-004 CELEXA EQ 60MG BASE TABLET / ORAL 1998-07-17 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N020822-001 CELEXA EQ 10MG BASE TABLET / ORAL AB RLD 2000-04-27 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N020822-002 CELEXA EQ 20MG BASE TABLET / ORAL AB RLD 1998-07-17 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N020822-003 CELEXA EQ 40MG BASE TABLET / ORAL AB RLD, RS 1998-07-17 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N020822-004 CELEXA EQ 60MG BASE TABLET / ORAL 1998-07-17 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N020822-001 CELEXA EQ 10MG BASE TABLET / ORAL AB RLD 2000-04-27 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N020822-002 CELEXA EQ 20MG BASE TABLET / ORAL AB RLD 1998-07-17 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N020822-003 CELEXA EQ 40MG BASE TABLET / ORAL AB RLD, RS 1998-07-17 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N020822-004 CELEXA EQ 60MG BASE TABLET / ORAL 1998-07-17 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N020822-001 CELEXA EQ 10MG BASE TABLET / ORAL AB RLD 2000-04-27 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N020822-002 CELEXA EQ 20MG BASE TABLET / ORAL AB RLD 1998-07-17 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N020822-003 CELEXA EQ 40MG BASE TABLET / ORAL AB RLD, RS 1998-07-17 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N020822-004 CELEXA EQ 60MG BASE TABLET / ORAL 1998-07-17 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N020822-001 CELEXA EQ 10MG BASE TABLET / ORAL AB RLD 2000-04-27 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N020822-002 CELEXA EQ 20MG BASE TABLET / ORAL AB RLD 1998-07-17 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N020822-003 CELEXA EQ 40MG BASE TABLET / ORAL AB RLD, RS 1998-07-17 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N020822-004 CELEXA EQ 60MG BASE TABLET / ORAL 1998-07-17 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N020822-001 CELEXA EQ 10MG BASE TABLET / ORAL AB RLD 2000-04-27 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N020822-002 CELEXA EQ 20MG BASE TABLET / ORAL AB RLD 1998-07-17 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N020822-003 CELEXA EQ 40MG BASE TABLET / ORAL AB RLD, RS 1998-07-17 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N020822-004 CELEXA EQ 60MG BASE TABLET / ORAL 1998-07-17 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N020822-001 CELEXA EQ 10MG BASE TABLET / ORAL AB RLD 2000-04-27 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N020822-002 CELEXA EQ 20MG BASE TABLET / ORAL AB RLD 1998-07-17 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N020822-003 CELEXA EQ 40MG BASE TABLET / ORAL AB RLD, RS 1998-07-17 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N020822-004 CELEXA EQ 60MG BASE TABLET / ORAL 1998-07-17 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N020822-001 CELEXA EQ 10MG BASE TABLET / ORAL AB RLD 2000-04-27 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N020822-002 CELEXA EQ 20MG BASE TABLET / ORAL AB RLD 1998-07-17 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N020822-003 CELEXA EQ 40MG BASE TABLET / ORAL AB RLD, RS 1998-07-17 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N020822-004 CELEXA EQ 60MG BASE TABLET / ORAL 1998-07-17 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N020822-001 CELEXA EQ 10MG BASE TABLET / ORAL AB RLD 2000-04-27 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N020822-002 CELEXA EQ 20MG BASE TABLET / ORAL AB RLD 1998-07-17 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N020822-003 CELEXA EQ 40MG BASE TABLET / ORAL AB RLD, RS 1998-07-17 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N020822-004 CELEXA EQ 60MG BASE TABLET / ORAL 1998-07-17 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N020822-001 CELEXA EQ 10MG BASE TABLET / ORAL AB RLD 2000-04-27 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N020822-002 CELEXA EQ 20MG BASE TABLET / ORAL AB RLD 1998-07-17 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N020822-003 CELEXA EQ 40MG BASE TABLET / ORAL AB RLD, RS 1998-07-17 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N020822-004 CELEXA EQ 60MG BASE TABLET / ORAL 1998-07-17 d06236e962d9…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 4 · 123 observed states.
Additional Listing Data#
Finished product Yes
Brand name base Celexa
Listing expiration 2026-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength CITALOPRAM HYDROBROMIDE 20 mg/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination I1E9D14F36 Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 6 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 200371 Internal RxNorm lookup 213344 Internal RxNorm lookup 213345 Internal RxNorm lookup 283672 Internal RxNorm lookup 284591 Internal RxNorm lookup 309314 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 0456-4020-01 Celexa 100 in 1 BOTTLE TABLET, FILM COATED 100 39 0456-4020-11 Celexa 10 in 1 BLISTER PACK TABLET, FILM COATED 10 39 0456-4020-63 Celexa 10 in 1 BOX, UNIT-DOSE TABLET, FILM COATED 10 39
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded citalopram hydrobromide ACTIVE INGREDIENT I1E9D14F36 CELEXA (CITALOPRAM HYDROBROMIDE) TABLET, FILM COATED [FOREST LABORATORIES, INC.] 18 citalopram ACTIVE MOIETY 0DHU5B8D6V CELEXA (CITALOPRAM HYDROBROMIDE) TABLET, FILM COATED [FOREST LABORATORIES, INC.] 18 cellulose, microcrystalline INACTIVE INGREDIENT OP1R32D61U CELEXA (CITALOPRAM HYDROBROMIDE) TABLET, FILM COATED [FOREST LABORATORIES, INC.] 18 copovidone INACTIVE INGREDIENT D9C330MD8B CELEXA (CITALOPRAM HYDROBROMIDE) TABLET, FILM COATED [FOREST LABORATORIES, INC.] 18 croscarmellose sodium INACTIVE INGREDIENT M28OL1HH48 CELEXA (CITALOPRAM HYDROBROMIDE) TABLET, FILM COATED [FOREST LABORATORIES, INC.] 18 FERRIC OXIDE RED INACTIVE INGREDIENT 1K09F3G675 CELEXA (CITALOPRAM HYDROBROMIDE) TABLET, FILM COATED [FOREST LABORATORIES, INC.] 18 FERRIC OXIDE YELLOW INACTIVE INGREDIENT EX438O2MRT CELEXA (CITALOPRAM HYDROBROMIDE) TABLET, FILM COATED [FOREST LABORATORIES, INC.] 18 glycerin INACTIVE INGREDIENT PDC6A3C0OX CELEXA (CITALOPRAM HYDROBROMIDE) TABLET, FILM COATED [FOREST LABORATORIES, INC.] 18 hypromelloses INACTIVE INGREDIENT 3NXW29V3WO CELEXA (CITALOPRAM HYDROBROMIDE) TABLET, FILM COATED [FOREST LABORATORIES, INC.] 18 lactose monohydrate INACTIVE INGREDIENT EWQ57Q8I5X CELEXA (CITALOPRAM HYDROBROMIDE) TABLET, FILM COATED [FOREST LABORATORIES, INC.] 18 magnesium stearate INACTIVE INGREDIENT 70097M6I30 CELEXA (CITALOPRAM HYDROBROMIDE) TABLET, FILM COATED [FOREST LABORATORIES, INC.] 18 polyethylene glycols INACTIVE INGREDIENT 3WJQ0SDW1A CELEXA (CITALOPRAM HYDROBROMIDE) TABLET, FILM COATED [FOREST LABORATORIES, INC.] 18 starch, corn INACTIVE INGREDIENT O8232NY3SJ CELEXA (CITALOPRAM HYDROBROMIDE) TABLET, FILM COATED [FOREST LABORATORIES, INC.] 18 titanium dioxide INACTIVE INGREDIENT 15FIX9V2JP CELEXA (CITALOPRAM HYDROBROMIDE) TABLET, FILM COATED [FOREST LABORATORIES, INC.] 18 CITALOPRAM HYDROBROMIDE ACTIVE INGREDIENT I1E9D14F36 CELEXA (CITALOPRAM HYDROBROMIDE) TABLET [PHYSICIANS TOTAL CARE, INC.] 2 CITALOPRAM ACTIVE MOIETY 0DHU5B8D6V CELEXA (CITALOPRAM HYDROBROMIDE) TABLET [PHYSICIANS TOTAL CARE, INC.] 2 CELLULOSE, MICROCRYSTALLINE INACTIVE INGREDIENT OP1R32D61U CELEXA (CITALOPRAM HYDROBROMIDE) TABLET [PHYSICIANS TOTAL CARE, INC.] 2 CROSCARMELLOSE SODIUM INACTIVE INGREDIENT M28OL1HH48 CELEXA (CITALOPRAM HYDROBROMIDE) TABLET [PHYSICIANS TOTAL CARE, INC.] 2 GLYCERIN INACTIVE INGREDIENT PDC6A3C0OX CELEXA (CITALOPRAM HYDROBROMIDE) TABLET [PHYSICIANS TOTAL CARE, INC.] 2 HYPROMELLOSES INACTIVE INGREDIENT 3NXW29V3WO CELEXA (CITALOPRAM HYDROBROMIDE) TABLET [PHYSICIANS TOTAL CARE, INC.] 2 LACTOSE MONOHYDRATE INACTIVE INGREDIENT EWQ57Q8I5X CELEXA (CITALOPRAM HYDROBROMIDE) TABLET [PHYSICIANS TOTAL CARE, INC.] 2 MAGNESIUM STEARATE INACTIVE INGREDIENT 70097M6I30 CELEXA (CITALOPRAM HYDROBROMIDE) TABLET [PHYSICIANS TOTAL CARE, INC.] 2 POLYETHYLENE GLYCOL INACTIVE INGREDIENT 3WJQ0SDW1A CELEXA (CITALOPRAM HYDROBROMIDE) TABLET [PHYSICIANS TOTAL CARE, INC.] 2 STARCH, CORN INACTIVE INGREDIENT O8232NY3SJ CELEXA (CITALOPRAM HYDROBROMIDE) TABLET [PHYSICIANS TOTAL CARE, INC.] 2 TITANIUM DIOXIDE INACTIVE INGREDIENT 15FIX9V2JP CELEXA (CITALOPRAM HYDROBROMIDE) TABLET [PHYSICIANS TOTAL CARE, INC.] 2
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 0456-4020 CELEXA (CITALOPRAM) TABLET, FILM COATED [ALLERGAN, INC.] 39 Current NDC, Legacy NDC, 3 package rows 20240628_4259d9b1-de34-43a4-85a8-41dd214e9177.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 0456-4020-63 00456402063 10 BLISTER PACK in 1 BOX, UNIT-DOSE (0456-4020-63) > 10 TABLET, FILM COATED in 1 BLISTER PACK (0456-4020-11) 10 blister pack 1998-07-17 0000-00-00 No No Current